Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma

BACKGROUND: Rosiglitazone (ROZ) and glimepiride (GLM) are antidiabetic agents used in the treatment of type 2 diabetes mellitus. A survey of the literature reveals that only one spectrophotometric method has been reported for the simultaneous determination of ROS and GLM in pharmaceutical preparatio...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Enany, Nahed M, Abdelal, Amina A, Belal, Fathalla F, Itoh, Yoshinori I, Nakamura, Mitsuhiro N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292994/
https://www.ncbi.nlm.nih.gov/pubmed/22277722
http://dx.doi.org/10.1186/1752-153X-6-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292994/
https://www.ncbi.nlm.nih.gov/pubmed/22277722
http://dx.doi.org/10.1186/1752-153X-6-9

Ejemplares similares